Glaxo Asthma Self-Management Program survey shows 14.7% decrease in night-time awakening.
Executive Summary
GLAXO ASTHMA PROGRAM REDUCES NIGHT-TIME AWAKENING 14.7%, according to a follow-up survey of the Asthma Self-Management Program conducted after six months. In a survey conducted in 137 patients from eight customer sites that adopted ASMP in 1996, 27% of participants reported no asthma-associated night-time waking prior to the program; 41.7% reporting undisturbed sleep six months after the program, Glaxo Wellcome reported, on an announcement of the survey findings on July 25.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth